Ledger.Open graph →
SEC Form D · filed April 11, 2025

Ernexa Therapeutics Inc

Offering
$7.2M
Sold
$7.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

William Wexler · Cambridge, MADirectorSandra Gurrola · Cambridge, MAExecSanjeev Luther · Cambridge, MAExec · DirectorJames Bristol · Cambridge, MADirectorPeter Cicala · Cambridge, MADirectorElena Ratner · Cambridge, MADirectorElena Ratner · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗